1. Development of an oral once-weekly drug delivery system for HIV antiretroviral therapy;Kirtane;Nat. Commun.,2018
2. FDA, VICTOZA® (liraglutide) injection, for subcutaneous use. https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/022341s027lbl.pdf (accessed December 20, 2022).
3. FDA, BYETTA® (exenatide) Injection. https://www.accessdata.fda.gov/drugsatfda_docs/label/2009/021773s9s11s18s22s25lbl.pdf (accessed December 20, 2022).
4. FDA, CDER, SANDOSTATIN® LAR DEPOT (octreotide acetate) for injectable suspension, for gluteal intramuscular use. https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/021008s043lbl.pdf (accessed December 20, 2022).
5. Oral delivery of therapeutic peptides and proteins: Technology landscape of lipid-based nanocarriers;Haddadzadegan;Adv. Drug Deliv. Rev.,2022